Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

biote Corp. Director's Dealing 2023

May 19, 2023

33946_dirs_2023-05-19_63b37b2a-58cd-4e76-a315-31fb6d0fa1ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: biote Corp. (BTMD)
CIK: 0001819253
Period of Report: 2023-05-17

Reporting Person: Cone Stephen Mark (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-17 Deferred Settlement RSU $ A 9524.00 Acquired Class A Common Stock (9524.00) Direct
2023-05-17 Stock Option (Right to Buy) $5.83 A 46809.00 Acquired 2033-05-16 Class A Common Stock (46809.00) Direct

Footnotes

F1: Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.

F2: The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the date of the Reporting Person's separation from service.

F3: All shares subject to the option award shall vest on the earlier of May 17, 2024 or the day prior to the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.